Oncology
This category brings together generic oncology medicines used in the treatment of a range of cancers, from chronic myeloid leukaemia and lung cancer to prostate cancer and multiple myeloma. The focus here is affordability: a generic cancer medicine contains the same active ingredient, in the same strength and dose form, as its branded originator, but is typically supplied at a lower cost. For patients and clinicians managing long courses of therapy, the price difference between branded and generic oncology drugs can be substantial.
Every product listed is produced by licensed manufacturers and corresponds to a well-established branded reference. For example, generic imatinib is the same active ingredient as branded Gleevec, generic osimertinib matches Tagrisso, and generic abiraterone corresponds to Zytiga. Comparisons on these pages are drawn only on the shared active ingredient, strength and formulation alongside cost — not on treatment outcomes. To understand how these therapies fit within wider cancer care, see our cancer medicines hub.
Oncology medicines are prescription-only and should be used only under the supervision of a specialist. The choice of drug, dose and schedule is a clinical decision made by your treating oncologist, and a valid prescription is required before any order can be dispensed. Medicines in this category are used as prescribed by a licensed medical professional. We provide worldwide delivery, and our team can help with questions about availability and pricing once your prescription is in place.
